Travere Therapeutics
TVTX
TVTX
128 hedge funds and large institutions have $1.21B invested in Travere Therapeutics in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2.2% more ownership
Funds ownership: 103.36% → 105.56% (+2.2%)
1% less funds holding
Funds holding: 129 → 128 (-1)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
Holders
128
Holding in Top 10
3
Calls
$14.6M
Puts
$9.99M
Top Buyers
| 1 | +$15.5M | |
| 2 | +$11.5M | |
| 3 | +$10.1M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$9.4M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.87M |
Top Sellers
| 1 | -$7.93M | |
| 2 | -$7.41M | |
| 3 | -$5.85M | |
| 4 |
BA
Boston Advisors
Boston,
Massachusetts
|
-$3.43M |
| 5 |
BC
Broadfin Capital
New York
|
-$3.17M |